AI-driven gene therapy idea wins EQT Impact Challenge 2026

In partnership with: EQT The grand finale of EQT Impact Challenge 2026 at Hong Kong’s M+ Museum in September saw some of Asia’s most promising deep-tech founders tackling challenges across climate and health. The initiative, backed by global investment firm EQT and its philanthropic arm EQT Foundation, provides young companies with crucial early-stage investment alongside access to a global network of industry experts, investors and mentors. After a seven-month journey that attracted more than 200 applicants and almost 6,000 public votes, five finalists took to the stage. Advent Gene Therapeutics, which was named this year’s winner, has recei (Source: South China Morning Post | Region: Beijing, China)